Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics published : This year save search
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
SLNO | News | $37.53 1.02% 1.01% 190K
|
Health Technology
| Email alert
Add to watchlist
nasdaq grants therapeutics
Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff
Published: 2024-04-19 (Crawled : 16:00) - biospace.com/
TXMD | News | $1.86 -1.59% -1.61% 10K
|
Health Technology
|
| O: -0.53%
H: 5.32%
C: -1.06%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: -1.23%
H: 0.94%
C: 0.76%
AMRN | News | $0.88 0.94% 0.93% 1M
|
Health Technology
|
| O: -6.35%
H: 2.3%
C: -1.15%
GOOGL | News S | $154.08 -1.24% -1.25% 32M
|
Technology Services
|
| O: 0.57%
H: 0.1%
C: -1.35%
GOOG | News S | $155.7 -1.12% -1.13% 20M
|
Technology Services
|
| O: 0.54%
H: 0.15%
C: -1.29%
OCX | News J | $2.495 -2.54% -2.61% 50K
|
Health Technology
|
| O: -1.93%
H: 0.39%
C: -1.57%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M
|
Health Technology
|
| O: -5.75%
H: 4.88%
C: -7.32%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 1.83%
C: 0.89%
PTCT | News S | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: -4.57%
H: 6.41%
C: 5.46%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -1.48%
H: 0.0%
C: -6.77%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -0.17%
H: 0.11%
C: -0.22%
RLYB | News | $1.75 4.79% 4.57% 310K
|
|
| O: -3.51%
H: 10.3%
C: 6.67%
biopharma
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
VERV | News | $6.64 -0.3% -0.3% 1.1M
|
Professional, Scientific, and T...
|
| O: -2.23%
H: 3.19%
C: 0.76%
for potential
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.42%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.84%
H: 0.86%
C: -0.62%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.58%
H: 0.99%
C: 0.97%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -3.05%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.18%
H: 0.84%
C: 0.6%
report reach therapeutics market
TScan Therapeutics Announces Closing of Upsized Public Offering
Published: 2024-04-19 (Crawled : 14:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: 1.04%
H: 4.55%
C: 0.0%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.35%
H: 1.39%
C: 0.33%
offering therapeutics
Preliminary Results for the Year Ended 31 December 2023
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
ATRX | News | $0.006 1724.82% 300
|
Manufacturing
|
| O: 26.26%
H: 0.0%
C: 0.0%
year for results
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
PRQR | News | $1.965 5.65% 5.34% 130K
|
Health Technology
|
| O: -1.04%
H: 8.95%
C: 4.74%
defense
Addex to Present at the Swiss Biotech Day 2024
Published: 2024-04-19 (Crawled : 05:00) - globenewswire.com
ADXN | News | $19.0 -9.35% -10.32% 20K
|
Health Technology
|
| O: -8.85%
H: 0.0%
C: -2.67%
day biotech
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
IKT | $2.1 0.19% 52K
|
Health Technology
|
| O: 0.95%
H: 0.47%
C: -3.77%
update therapeutics development
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
ANIK | $25.84 1.61% 1.59% 49K
|
Health Technology
|
| O: -0.66%
H: 1.92%
C: 1.41%
first financial results
Windtree Therapeutics Announces Reverse Stock Split - April 18, 2024
Published: 2024-04-18 (Crawled : 20:00) - biospace.com/
WINT | $0.3419 0.62% 0.61% 470K
|
Health Technology
|
| O: -30.25%
H: 0.0%
C: 0.0%
therapeutics
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
cell meeting therapeutics therapy
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
YS | News | $0.7013 -17.98% -21.92% 420K
|
n/a
|
| O: -7.45%
H: 0.0%
C: 0.0%
hepatitis vaccine license granted biopharma virus trial
Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
COYA | $7.87 -6.75% -7.24% 54K
|
|
| O: -1.1%
H: 0.0%
C: 0.0%
drug als therapeutics development
Form Bio Establishes Scientific Advisory Board, Comprised of Renowned Experts in Cell and Gene Therapy, for Advancing AI-Driven Therapies
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
FDMT M | $25.29 2.06% 2.02% 630K
|
Health Technology
|
| O: -1.23%
H: 0.0%
C: 0.0%
cell for
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ONCT | $8.97 4.3% 4.12% 4.5K
|
Health Technology
| Email alert
Add to watchlist
onct-534 first cancer treatment for study
NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting
Published: 2024-04-18 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | $1.435 -5.59% -5.92% 120K
|
|
| O: -0.63%
H: 1.89%
C: -4.4%
neurology presentation readout positive topline meeting
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -0.43%
H: 4.57%
C: 0.0%
briumvi neurology sclerosis for meeting therapeutics
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
MNPR | $0.636 -6.19% -6.6% 33K
|
Health Technology
|
| O: 6.06%
H: 2.86%
C: -2.86%
nuclear presentation for meeting imaging molecular
Windtree Therapeutics Announces Reverse Stock Split
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
WINT | $0.3419 0.62% 0.61% 470K
|
Health Technology
|
| O: -30.25%
H: 0.0%
C: 0.0%
therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.